Nexstim Plc · OMXHEX:NXTMH
Nexstim — Redeye Life Science Day 2021
11 slides from Nexstim's conference presentation, Nov 11, 2021
Slide 1: Nexstim as an investment
Nexstim as an investment Personalized brain diagnostics and therapy Mikko Karvinen| CEO| Nexstim Plc Redeye Life Science Day 2021| Stockholm | 11 November 2021 Nexstim Oyj
Slide 2: Content of the Presentation
Content of the Presentation • Nexstim story • Megatrends that support our growth • Business and products • Strategic objectives • Why invest in Nexstim? • Business update and financial key figures Nexstim Oyj Nexstim Plc Public Presentation 2
Slide 3: Nexstim Story
Nexstim Story Nexstim is a Finnish, globally operating medical technology company. MISSION VISION VALUES We enable personalized and Our innovations create a Science and clinical evidence effective therapies and possibility for a better life. diagnostics for challenging Financial success brain diseas
Slide 4: Megatrends that Support our Growth
Megatrends that Support our Growth Nexstim’s unique proprietary neuronavigated TMS-technology for both diagnostic and therapy applications. • Population aging and a significant decline in the Aging population working-age and able population in Western countries • Brain diseases increase with aging T
Slide 5: Our Business and Products
Our Business and Products Commercial Business System Application Europe United States Status NBS Diagnostics (Navigated Over 190 Pre-surgical CE marked FDA approved Business Brain systems sold mapping Stimulation) FDA approved Depression CE marked with existing NBT® Over 40 reimbursement Therapy (Na
Slide 6: Key Strategic Objectives for Year 2021 – execution is progressing
Key Strategic Objectives for Year 2021 – execution is progressing Focus on achieving profitable revenue growth and strict management 1 of operating expenses Report first results from the two new pilot studies in treating severe depression and/or chronic pain patients with accelerated therapy 2 treat
Slide 7: Why Invest in Nexstim? 1/2
Why Invest in Nexstim? 1/2 1 2 3 4 NEXSTIM IS A UNIQUE SCALABLE COMMERCIAL PRODUCT MEGATRENDS SUPPORT MEDICAL TECHNOLOGY GROWTH TECHNOLOGY PLATFORM PORTFOLIO IN A STRONGLY OUR GROWTH COMPANY IN A DEFENSIVE REGULATED INDUSTRY INDUSTRY Nexstim is a Finnish, globally Our neuronavigated TMS We operate i
Slide 8: Why Invest in Nexstim? 2/2
Why Invest in Nexstim? 2/2 5 6 7 FOCUS IN THE LONG-TERM RECURRING REVENUE STRONG ORGANIZATION AND SHAREHOLDER VALUE SUPPORTS OUR GROWTH COMMITTED TEAM OF EXPERTS Nexstim is an investment Our business is built on a solid Our Board and management team opportunity due to increased base and our systems
Slide 9: Nexstim Business Summary H1 2021
Nexstim Business Summary H1 2021 • Nexstim’s historically best first half measured by net sales, operating result and result for the review period • Our business has adapted very well to the changes in the operating environment caused by the COVID-19 pandemic • System sales were EUR 1.6M (2020 H1: E
Slide 10: Thank you!
Thank you! Nexstim Oyj Nexstim Plc Public Presentation 10
Slide 11: Important Information
Important Information This document and the information contained herein are being presented by Nexstim Oyj other than the date of this presentation. Nothing contained herein is, or should be relied upon (“Nexstim” or the “Company”). In connection with any presentation or review of this document, as